Heart failure & cardiomyopathies

The HEARTRISK6 Scale: Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients

JACC AdvPublished Risk prediction model development study

Authors' conclusion

Using 3 large prospectively collected datasets, we created a concise and sensitive risk scale for patients with AHF in the ED.

Study context

Population
Emergency department (ED) patients requiring treatment for acute heart failure (AHF)
Participants
2,246 patients3 cohorts
Exposure
HEARTRISK6 admission thresholds ≥1 vs ≥2
Outcome
Short-term serious outcomes (SSO): death <30 days, intubation or NIV, MI, or relapse to ED <14 days
Methodological detailspooled prospective cohorts, 10 tertiary care hospital EDs, logistic regression with AIC-based step-down, bootstrapped internal validation
  • Pooled prospective cohorts
  • 10 tertiary care hospital EDs
  • Logistic regression with AIC-based step-down
  • Bootstrapped internal validation

Main finding

As reported in the abstract

SSO prediction
StrategySensitivitySpecificity
Threshold ≥1
88.3% (95% CI: 83.9%-91.8%)Sensitivity on a scale from 0 to 100 percent
24.7% (95% CI: 22.8%-26.7%)Specificity on a scale from 0 to 100 percent
Threshold ≥2
71.5% (95% CI: 65.9%-76.7%)Sensitivity on a scale from 0 to 100 percent
50.1% (95% CI: 47.9%-52.4%)Specificity on a scale from 0 to 100 percent

Sensitivity

Threshold ≥188.3% (95% CI: 83.9%-91.8%)
Threshold ≥271.5% (95% CI: 65.9%-76.7%)
Sensitivity on a scale from 0 to 100 percent

Specificity

Threshold ≥124.7% (95% CI: 22.8%-26.7%)
Threshold ≥250.1% (95% CI: 47.9%-52.4%)
Specificity on a scale from 0 to 100 percent
SSOs in cohort
281 (12.5%)
Deaths
70 (3.1%)

Observational data: associations, not effects.

Original publication

The HEARTRISK6 Scale: Predicting Short-Term Serious Outcomes in Emergency Department Acute Heart Failure Patients. JACC Adv. Published 24 May 2024. doi:10.1016/j.jacadv.2024.100988

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.